Results 281 to 290 of about 185,125 (388)

Randomised clinical trial: alginate (Gaviscon Advance) vs. placebo as add‐on therapy in reflux patients with inadequate response to a once daily proton pump inhibitor

Alimentary Pharmacology and Therapeutics, 2016
C. Reimer, A. Lødrup, Gary B. Smith, J. Wilkinson, P. Bytzer   +4 more
semanticscholar   +1 more source

COX-2 inhibitor compared with proton pump inhibitor in the prevention of recurrent ulcer complications in high-risk patients taking NSAIDs

, 2001
Kam‐Chuen Lai, Kent‐Man Chu, Wai‐Mo Hui, Chun-Yu Wong, Wayne Hc Hu, Wai-Man Yuen, Man‐Fung Yuen, On-On Chan, Ching‐Lung Lai, Ka-Kit Lau, Chi-Kuen Chan, Shiu‐Kum Lam   +11 more
openalex   +1 more source

Pharmacokinetic Prediction and Cytotoxicity of New Quercetin Derivatives

Chemistry &Biodiversity, EarlyView.
ABSTRACT Quercetin (QUE) possesses various pharmacological properties; however, its low bioavailability and solubility hinder its beneficial effects. Enzymatic glycosylation has been explored to improve these aspects. In the present study, we used a sucrose phosphorylase variant to catalyze the regioselective transglucosylation of QUE, predicted the ...
Michele Goulart dos Santos, Marie Demonceaux, Lucia Emanueli Schimith, Marine Goux, Claude Solleux, Ana Luiza Muccillo‐Baisch, Bruno Dutra Arbo, Corinne Andre‐Miral, Mariana Appel Hort   +8 more
wiley   +1 more source

Laryngeal Manifestations of Gastroesophageal Reflux Disease (GERD) in Pediatric Patients: The Usefulness of Therapeutic (Proton Pump Inhibitor (PPI)) Trials.

, 2001
Hideto Saigusa, Seiji Niimi, Utako Saigusa, Toshiaki Yagi, Toshifumi Takakuwa   +4 more
openalex   +2 more sources

Helicobacter pylori, esophageal precancerous lesions, and proton pump inhibitor overuse. [PDF]

World J Gastroenterol
Zhang F, Zhang H, Liu YM, Tang FS.
europepmc   +1 more source

Predicting Liquid Organic Hydrogen Carrier Saturation in Dehydrogenation Cell Gas Diffusion Layers for Hydrogen Storage

ChemCatChem, EarlyView.
The influence of gas diffusion layer (GDL) microstructures on mass transport and methylcyclohexane saturation (MCH) in a dehydrogenation cell was investigated using pore network modeling. We reveal that GDLs with larger pore diameters (dpore) and lower tortuosity (τ) enable enhanced MCH invasion, thereby improving reactant concentration at the catalyst.
Aida Farsi, Lijun Zhu, Tess Seip, Aimy Bazylak   +3 more
wiley   +1 more source

Enhanced gastroprotective and anti-ulcerogenic activities in rats of a new class of proton pump inhibitor containing nitrosothiol nitric oxide donor

, 2001
J. K. Saha, Tiansheng Wang, Richardson Stewart, Mark Trocha, Mathew J. Shumway, David S. Garvey, L. Gordon Letts, M. Michael Wolfe, S. William Tam   +8 more
openalex   +1 more source

Hypomagnesemia Causing Convulsions in a Patient Taking a Proton Pump Inhibitor: A Case Report. [PDF]

Cureus
Sato T, Ohashi R, Konishi K, Cho T, Ichibayashi R.   +4 more
europepmc   +1 more source

Electrocatalytic Glucose Upgrading by Sulfonated Carbon for Sustainable Manufacturing

ChemCatChem, EarlyView.
We are one step closer to sustainable manufacturing after successfully converting glucose into various raw materials (oxalic acid, gluconic acid, tartaric acid, maleic acid, glycolic acid, arabinose, formic acid, acetic acid, and 5‐hydroxymethylfurfural) by electrocatalytic oxidation with a sulfonated carbon catalyst. Abstract In a sustainable economy,
Andrew Carkner, Caio Furukawa, Alaleh Esfandiari, Ali Seifitokaldani, Jan Kopyscinski   +4 more
wiley   +1 more source

Change in Symptoms and Mucosal Findings after Proton Pump Inhibitor in Patients with Laryngopharyngeal Reflux. [PDF]

Int Arch Otorhinolaryngol
Park MW, Kang SJ, Wee JH.
europepmc   +1 more source